Friedrich von Bohlen und Halbach, Ph.D. (Chairman)

Dr. Friedrich von Bohlen is co-founder and CEO of Molecular Health GmbH. He holds a diploma in biochemistry from the University of Zurich and a PhD in neurobiology from the Swiss Federal Institute of Technology (ETH) in Zurich. After holding various leadership positions at Fresenius AG, FAG Kugelfischer KGaA and WASAG Chemie AG, he co-founded LION bioscience AG in 1997, being its CEO until 2003. From 2004 until 2022 he managed the biotech investments of the SAP Co-Founder Dietmar Hopp and his family through the investment firm dievini as Co-Founder and Managing Director.

He is Chairman of the Board of Apogenix GmbH as well as Board Member of Heidelberg Pharma AG. He is also Chairman of the Board of InnoSource Ventures AG, Zurich, Member of the Advisory Board of the Wyss Center for Bio and Neuroengineering, Geneva, and Member of the Board of Trustees of the Max Planck Institute for Medical Research, Heidelberg.

Prof. Peter Krammer, M.D.
(Vice Chairman)

Prof. Peter Krammer, M.D., is Head of the Division of Immunogenetics in the Tumor Immunology Program at the German Cancer Research Center (DKFZ) and a member of the Board of Directors of the National Center for Tumor Diseases (NCT) in Heidelberg, Germany. He studied medicine at the University of Freiburg, Germany, in St. Louis, MO, USA, and in Lausanne, Switzerland. Prof. Krammer is one of the world’s most renowned apoptosis researchers and has received numerous prestigious awards, including the Robert Koch Prize, the German Cancer Award, the Kitasato-Behring Prize, the Avery-Landsteiner Prize, the Ernst Jung Prize, and the Order of Merit of the Federal Republic of Germany.

Prof. Josef Puchta, Ph.D.

Prof. Josef Puchta, Ph.D., was Commercial Director of the German Cancer Research Center (DKFZ) in Heidelberg, Germany, from 1996 to 2019. He studied economics at the Universities of Augsburg and Erlangen-Nuremberg, and received his doctorate degree (Dr. rer. pol.) from the University of Oldenburg in Germany. In 1983 and 1984, Prof. Puchta conducted research in Canada. From 1987 to 1992, he worked for the German Foundation for International Development in Berlin and at the Senate Department for Economics and Technology of the State of Berlin. From 1992 to 1996, he served as Administrative Director of the German Institute of Human Nutrition in Potsdam, Germany. In January 2011, he was appointed Honorary Professor at the University of Applied Sciences in Mannheim, Germany..

Mathias Hothum, Ph.D.

Mathias Hothum, Ph.D., is owner of HMM-Consulting and managing director of dievini Hopp BioTech holding GmbH & Co. KG. He received his graduate degree in economics from the University of Mannheim and his doctorate degree from the University of Magdeburg in Germany. Over the past 20 years, he has gained extensive experience as an economist in the fields of healthcare, health services, and life sciences. He specializes in pricing, reimbursement, and in the evaluation of medium-sized and publicly traded companies. At dievini, his focus is on managerial accounting and strategic planning for portfolio companies.